Midlife Body Manual

Menopause and Libido: What Changes and What to Discuss

Desire shifts in midlife. It is not just hormones, and it is not just aging. Here is what the evidence says about what is happening and what can help.

It is not something people bring up easily. The desire that used to arrive on its own has gone quiet, or sex that was comfortable is now painful, or you are interested in theory but your body is not cooperating with the reality. Changes in sexual function during midlife are among the most common experiences of the menopause transition and among the least discussed, both at home and in clinicians’ offices.

The plain version: changes in sexual desire and function during menopause typically have multiple contributors. Vaginal dryness and pain from declining estrogen are often the most straightforward to treat. Declining testosterone may reduce spontaneous desire. Sleep disruption, mood changes, medications, relationship dynamics and body image all play a role. There is no single solution because there is rarely a single cause. But most of the contributing factors are treatable once they are identified.

What’s going on

Data from the SWAN study, which followed nearly 1,400 women through the menopause transition, showed a significant decline in sexual desire, arousal and frequency across the transition, with the most marked changes occurring after the final menstrual period [1]. The Melbourne Women’s Midlife Health Project found similar patterns, with prior sexual functioning, a change in partner, and feelings toward the partner being significant predictors alongside hormonal status [5].

Several things happen at once. Estrogen decline leads to vaginal atrophy: the vaginal walls thin, lubrication decreases, and the tissue becomes more fragile. Sex that was previously comfortable can become painful (dyspareunia). Understandably, pain reduces interest. This is not a psychological issue. It is a physical change with a direct effect on behavior.

Testosterone, which plays a role in sexual desire, declines gradually with age. By midlife, levels are roughly half of their peak. For some people, this decline contributes to a loss of spontaneous desire, the kind that arrives unbidden rather than in response to stimulation [6].

Sleep disruption from night sweats or insomnia reduces energy and interest in everything, including sex. Mood changes, whether depression, anxiety, or the general irritability that accompanies disrupted sleep and hormonal fluctuation, also affect desire. And body composition changes can alter how someone feels about themselves, which feeds into the picture.

Then there are the relationship factors. A long partnership has its own trajectory. Desire in a 25-year relationship does not operate the same way as desire in a new one, regardless of hormones. Partner health, relationship satisfaction and communication patterns all matter.

This is why addressing changes in sexual function during menopause usually requires looking at the whole picture rather than reaching for a single prescription.

Is it the change, or something else?

Typical in menopause Overlaps with other conditions Needs prompt attention
Vaginal dryness making sex uncomfortable Medication side effects (SSRIs, antihistamines, blood pressure drugs) Pain during intercourse that is severe or worsening
Reduced spontaneous desire Depression or anxiety affecting interest Vaginal bleeding during or after intercourse
Slower arousal or less intense response Thyroid disease (hypothyroidism reduces libido) New vulvar lesions or persistent irritation
Difficulty with orgasm Relationship dissatisfaction or stress Distress about sexual changes that is affecting daily life

A clinician can help sort through what is contributing. Sometimes the fix is straightforward (treating vaginal dryness). Sometimes it involves multiple approaches.

What helps, and how well

Vaginal estrogen. For people whose primary issue is painful intercourse due to vaginal dryness and atrophy, local estrogen therapy is often the most effective intervention. It restores moisture, elasticity and comfort. For many people, addressing the pain directly brings back a willingness to engage that was lost when sex became uncomfortable [2].

How strong is the evidence? Strong for vaginal estrogen treating dyspareunia and vaginal atrophy.

Lubricants and moisturizers. Lubricants reduce friction during intercourse. Moisturizers (used regularly, not just during sex) help maintain vaginal moisture between uses. These are available without a prescription and are a reasonable first step, particularly for people with mild symptoms or those who prefer non-hormonal options.

Testosterone. For people whose primary issue is low desire (not pain or dryness), testosterone therapy may be considered. A global consensus statement recommends it for postmenopausal women with hypoactive sexual desire disorder after other causes have been addressed [6]. The benefit is modest but clinically meaningful for some. NICE also recommends considering testosterone for low desire that has not responded to HRT alone [4].

Psychological and relationship approaches. CBT and sex therapy have evidence for sexual difficulties, including those related to menopause. They address the thoughts, expectations and relationship dynamics that contribute to sexual dissatisfaction. When desire is affected by mood, body image or relationship stress, these approaches can be as important as medical treatment.

Medication review. Some medications commonly prescribed in midlife (SSRIs, beta-blockers, certain blood pressure medications) can reduce desire or arousal. A clinician can review whether any current medications might be contributing and whether alternatives are available.

What does not help much. Over-the-counter “libido supplements” for women have very limited evidence. Products marketed as “female Viagra” (flibanserin) have modest effects and notable side effects. The supplement aisle is full of promises that the evidence does not support.

Take this to your appointment

  1. I have noticed changes in my sexual desire and function. Can we talk about what might be contributing?
  2. Is my vaginal dryness significant enough to warrant treatment?
  3. I am taking [medication]. Could it be affecting my desire or arousal?
  4. Would testosterone therapy be appropriate for my situation?
  5. Can you recommend a therapist or sex therapist who has experience with menopause-related sexual concerns?

A fictional example

This example is fictional and illustrative. Rachel is not a real person.

Rachel, 52, has not had sex with her partner in four months. She used to initiate regularly. Now the idea feels remote, and when they tried recently, intercourse was painful enough to stop. She feels guilty and frustrated. Her clinician asks about the pain (vaginal dryness on exam), her mood (sleeping poorly from night sweats, mildly anxious), her medications (an SSRI started six months ago for the anxiety), and her relationship (good, but they have stopped talking about the issue). They start vaginal estrogen for the dryness, discuss whether a different antidepressant might have fewer sexual side effects, and suggest she and her partner see a couples therapist to reopen the conversation. At three months, the pain has resolved and desire is returning. She plans to continue the vaginal estrogen.

See a clinician promptly if… you have any bleeding after 12 months without a period, very heavy or prolonged bleeding, new chest pain, a painful swollen leg or sudden shortness of breath, or low mood that won’t lift. If you are thinking about harming yourself, call or text 988 in the US, or call 911 in an emergency. This article is general education, not medical advice.

Related reading: Vaginal Dryness and Urinary Symptoms in Menopause | Testosterone in Menopause: What the Evidence Supports

Frequently asked questions

Does menopause always reduce sex drive?

Not always. Many people notice a decline in desire during and after the menopause transition, but experiences vary widely. Some people notice little change, and some find that certain aspects of their sexual life improve when concerns about pregnancy or periods are gone.

Is it normal to lose interest in sex after menopause?

Changes in desire are common and are not a sign that something is wrong with you as a person. However, if the change is distressing, it is worth discussing with a clinician because several treatable factors often contribute.

Can vaginal dryness be treated without hormones?

Yes. Vaginal moisturizers (used regularly) and lubricants (used during intercourse) are non-hormonal options. Vaginal DHEA is another option. For many people, addressing dryness and discomfort directly improves the sexual experience even if spontaneous desire does not fully return.

Should I talk to my doctor about low libido?

If the change is bothering you, yes. Clinicians can check for contributing factors like vaginal atrophy, thyroid disease, depression, medication side effects and relationship issues, and discuss treatment options tailored to what is driving the change.

Sources and further reading

  1. Avis et al. — Longitudinal changes in sexual functioning as women transition through menopause

    Menopause, 2017;24(1):29-39. SWAN data on 1,390 women documenting changes in sexual function across the menopause transition.

  2. The Menopause Society — 2020 GSM Position Statement

    Position statement on genitourinary syndrome of menopause, including effects on sexual function.

  3. Shifren et al. — Sexual problems and distress in United States women

    Obstetrics and Gynecology, 2008;112(5):970-978. Survey of 31,581 women examining the prevalence of sexual problems across age groups.

  4. NICE NG23 — Menopause: diagnosis and management

    UK guideline recommending vaginal estrogen for urogenital symptoms and consideration of testosterone for low desire.

  5. Dennerstein et al. — Factors affecting sexual functioning of women in the mid-life years

    Climacteric, 2005;8(4):351-358. Melbourne Women's Midlife Health Project, prospective study examining predictors of sexual functioning through the menopause transition.

  6. Davis et al. — Global Consensus Position Statement on the Use of Testosterone Therapy for Women

    Journal of Clinical Endocrinology and Metabolism, 2019;104(10):4660-4666. International consensus on testosterone for postmenopausal women with low desire.

Sources checked October 19, 2026. This is an editorial summary, not a systematic review or individual advice.

Get new articles by email

New articles from Midlife Body Manual, sent to your inbox. Unsubscribe at any time.

Related articles